Pharmacyclics Inc. (PCYC) Management Discusses Q2 2013 Resutls (Webcast)

 |  About: Pharmacyclics, Inc. (PCYC)
by: SA Transcripts

Pharmacyclics (PCYC): FQ3 EPS of $0.25 beats by $0.06. Revenue of $54.7M beats by $2.7M. (PR)

The following audio is from an earnings conference call that began on July 31, 2013, at 4:30 PM ET. The audio is live-streaming while the call is active, and can be replayed upon its completion.